Rockefeller Capital Management L.P. Bridge Bio Pharma, Inc. Transaction History

Rockefeller Capital Management L.P.

$34.7 Billion
Q2 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 36,942 shares of BBIO stock, worth $921,333. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,942

Previous 41,012 9.92%

Holding current value

$921,333

Previous $1.27 Million 26.26%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$23.0 - $31.04 $93,610 - $126,332	-4,070 Reduced 9.92%	36,942 $935,000
Q1 2024 May 14, 2024	SELL	$27.35 - $40.45 $13,128 - $19,416	-480 Reduced 1.16%	41,012 $1.27 Million
Q4 2023 Feb 14, 2024	SELL	$24.02 - $43.89 $16,814 - $30,723	-700 Reduced 1.66%	41,492 $1.68 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $274,935 - $569,892	-16,278 Reduced 27.84%	42,192 $1.11 Million
Q2 2023 Aug 14, 2023	BUY	$13.29 - $18.01 $123,171 - $166,916	9,268 Added 18.84%	58,470 $1.01 Million
Q1 2023 May 17, 2023	BUY	$7.17 - $18.55 $27,855 - $72,066	3,885 Added 8.57%	49,202 $815,000
Q4 2022 Mar 06, 2023	SELL	$6.74 - $11.52 $34,010 - $58,129	-5,046 Reduced 10.02%	45,317 $345,000
Q3 2022 Nov 02, 2022	SELL	$7.94 - $12.36 $130,819 - $203,643	-16,476 Reduced 24.65%	50,363 $500,000
Q2 2022 Aug 12, 2022	SELL	$5.21 - $12.14 $122,169 - $284,670	-23,449 Reduced 25.97%	66,839 $606,000
Q1 2022 May 13, 2022	SELL	$7.34 - $17.16 $7.48 Million - $17.5 Million	-1,018,945 Reduced 91.86%	90,288 $915,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $3.1 Million - $14.5 Million	272,319 Added 32.54%	1,109,233 $18.5 Million
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $226,382 - $310,279	4,830 Added 0.58%	836,914 $39.2 Million
Q2 2021 Aug 10, 2021	BUY	$46.47 - $63.93 $578,644 - $796,056	12,452 Added 1.52%	832,084 $50.7 Million
Q1 2021 May 11, 2021	BUY	$55.47 - $72.35 $2.36 Million - $3.08 Million	42,601 Added 5.48%	819,632 $50.5 Million
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $29.8 Million - $55.3 Million	777,031 New	777,031 $55.3 Million

Others Institutions Holding BBIO

# of Institutions

292

Shares Held

175M

Call Options Held

8.66M

Put Options Held

2.76M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.7B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Bridge Bio Pharma, Inc. Transaction History